Active ingredientGemigliptin TartrateCat. No. P-G026-001CAS 1374639-74-3Family · Pharmaceutical analytical standards
Gemigliptin
An oral antidiabetic of the DPP-4 inhibitor class (the gliptins), approved in June 2012 in South Korea, where it was developed. It is taken once a day in type 2 diabetes. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The dose is always the same, 50 mg a day: it does not need to be adjusted even for people with kidney or liver problems.
Go to the active ingredient →Active ingredientGemigliptin TartrateCat. No. P-G026-001CAS 1374639-74-3
Active ingredientGemigliptin Tartrate SesquihydrateCat. No. P-G026-002CAS 1375415-82-9
Isotopically labelledGemigliptin-d4 HClCat. No. P-G026-003
Impurity(R)-Gemigliptin L-TartrateCat. No. P-G026-004
ImpurityGemigliptin Impurity 1Cat. No. P-G026-009
ImpurityGemigliptin Impurity 2Cat. No. P-G026-010
ImpurityGemigliptin Impurity 3Cat. No. P-G026-011
Impurityrac-Gemigliptin TartrateCat. No. P-G026-013No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.